Indivior Pharmaceuticals Inc Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue317.0M358.0M314.0M302.0M266.0M299.0M307.0M299.0M
Cost of Goods Sold40.0M64.0M62.0M52.0M44.0M23.0M69.0M79.0M
Gross Profit277.0M294.0M252.0M250.0M222.0M276.0M238.0M220.0M
R&D Expenses16.0M17.0M20.0M21.0M22.0M31.0M22.0M26.0M
Operating Expenses140.0M172.0M153.0M178.0M156.0M180.0M234.0M338.0M
Operating Income137.0M122.0M99.0M72.0M66.0M96.0M4.0M-118.0M
Other Income / Gains-22.0M-41.0M-62.0M-10.0M-7.0M-8.0M-5.0M-3.0M
Net Income89.0M102.0M42.0M18.0M47.0M59.0M4.0M-97.0M
EPS (Diluted)0.710.820.340.140.380.450.03-0.72
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.8740.8210.8030.8280.8350.9230.7750.736
General And Administrative Expenses000158.0M65.0M-302.0M208.0M152.0M
Selling And Marketing Expenses000067.0M255.0M00
Selling General And Administrative Expenses124.0M155.0M133.0M158.0M132.0M-47.0M208.0M152.0M
Other Expenses000-1.0M2.0M196.0M4.0M160.0M
Cost And Expenses180.0M236.0M215.0M230.0M200.0M203.0M303.0M417.0M
Interest Income3.0M6.0M6.0M6.0M4.0M5.0M5.0M6.0M
Interest Expense7.0M6.0M12.0M15.0M12.0M13.0M10.0M9.0M
Depreciation And Amortization2.0M5.0M5.0M5.0M5.0M5.0M13.0M6.0M
Ebitda139.0M127.0M104.0M82.0M76.0M106.0M22.0M-106.0M
Ebitdaratio0.4380.3550.3310.2720.2860.3550.072-0.355
Operating Income Ratio0.4320.3410.3150.2380.2480.3210.013-0.395
Income Before Tax115.0M81.0M37.0M62.0M59.0M88.0M-1.0M-121.0M
Income Before Tax Ratio0.3630.2260.1180.2050.2220.294-0.003-0.405
Income Tax Expense26.0M-21.0M-5.0M44.0M11.0M28.0M-5.0M-23.0M
Net Income Ratio0.2810.2850.1340.060.1770.1970.013-0.324
Epsdiluted0.690.820.330.140.380.450.03-0.72
Weighted Average Shs Out125.4M125.0M125.0M123.7M123.7M126.6M132.1M134.8M
Weighted Average Shs Out Dil129.0M125.0M129.0M123.7M123.7M128.1M133.6M134.8M